FDA Authorizes New Saliva Sample Collection Method for High-Throughput, Automated COVID-19 Testing System

FDA Authorizes New Saliva Sample Collection Method for High-Throughput, Automated COVID-19 Testing System CARLSBAD, Calif., Oct. 18, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) to run COVID-19 tests from saliva samples collected with the... Read more

Thermo Fisher Scientific Unveils New Clinical and Research Lab Innovations at AACC 2021

Thermo Fisher Scientific Unveils New Clinical and Research Lab Innovations at AACC 2021 New instruments, assays and controls improve speed, sensitivity and flexibility for clinical testing and research related to COVID-19, cell & gene therapy, autoimmune disease and drugs of abuse ATLANTA, Sept. 28, 2021 /PRNewswire/ — AACC 2021 –Thermo Fisher Scientific, the world leader in... Read more

First Net Zero Mass Spectrometer Launched to Support Greener Future

Thermo Scientific Delta Q IRMS is the first product developed under ground-breaking IsoFootprint initiative to tackle CO₂ emissions for more sustainable science BREMEN, Germany, Sept. 23, 2021 /PRNewswire/ — The launch of the world’s first net zero mass spectrometer (MS) will make it easier than ever for scientists working across geoscience, food and beverage, environmental... Read more

Thermo Fisher Expands Capabilities with its Multichannel NanoDrop Eight UV-Vis Microvolume Spectrophotometer

Thermo Fisher Expands Capabilities with its Multichannel NanoDrop Eight UV-Vis Microvolume Spectrophotometer New instrument measures the purity of undiluted biological samples, offering a unique combination of measurement speed and sample quality and quantity assessments HILLSBORO, Ore., Sept. 22, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Thermo Scientific... Read more

Complete AAV Production System Enables Scalable Gene Therapy Workflows

New Gibco AAV-MAX Helper Free AAV Production System helps reduce production costs and streamline transition from research to clinical environments CARLSBAD, Calif., Sept. 20, 2021 /PRNewswire/ — Addressing the need to make adeno-associated virus (AAV) production more efficient and scalable, Thermo Fisher Scientific has launched the integrated Gibco AAV-MAX Helper Free AAV Production System*, a complete,... Read more

Thermo Fisher Scientific Adds Digital PCR to Genetic Analysis Capabilities

Applied Biosystems QuantStudio Absolute Q Digital PCR System*, the first integrated digital PCR solution, is ideal for oncology, cell and gene therapy development and other research applications WALTHAM, Mass., Sept. 20, 2021 /PRNewswire/ — Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, today launched the Applied Biosystems QuantStudio Absolute Q Digital PCR... Read more

FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda's Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations

FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda’s Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations Oncomine Dx Target Test now approved as CDx for five targeted NSCLC therapies in the U.S. CARLSBAD, Calif., Sept. 15, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher... Read more

New Mass Spectrometry Portfolio Leverages Enhanced Hardware and Software to Advance Quantitative Analysis

New Mass Spectrometry Portfolio Leverages Enhanced Hardware and Software to Advance Quantitative Analysis Thermo Scientific TSQ Plus triple quadrupole mass spectrometer portfolio meets productivity demands through improved speed and sensitivity SAN JOSE, Calif., Sept. 8, 2021 /PRNewswire/ — Lab managers, technology leaders and principal scientists in pharmaceutical, food and environmental laboratories can now benefit from accelerated... Read more

FDA Approves NGS-Based Companion Diagnostic for Previously Treated IDH1-Mutated Cholangiocarcinoma

FDA Approves NGS-Based Companion Diagnostic for Previously Treated IDH1-Mutated Cholangiocarcinoma CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for TIBSOVO CARLSBAD, Calif., Aug. 25, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted pre-market approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to... Read more

Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization

Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization – Establishes Thermo Fisher as a global leader in the attractive and high growth clinical research services industry – Adds highly complementary services for the company’s fastest growing end market – Offers both meaningful cost and revenue synergies which will further accelerate growth... Read more